Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Dec 15, 2020
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- NICHD Adverse Event, Unanticipated Problem, and Serious Adverse Event Reporting Guidance
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Clarification on Prohibition on Expending NIH Grant Funds for Covered Telecommunications Equipment or Services
National Institutes of Health
General Notices
- Notice of Informational Webinar for RFA-CA-20-055, RFA-CA-20-056, and RFA-CA-20-057: "Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)"
National Cancer Institute
- Notice of Pre-Application Webinar for the NCI-CRUK Cancer Grand Challenges
National Cancer Institute
- Notice of Pre-Application Webinar for RFA-DK-20-022, Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Pre-Application Webinar for RFA-DK-20-023, Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Findings of Research Misconduct
National Institutes of Health
- Required Use of Two-Factor Authentication Using Login.Gov for eRA's External Modules in 2021
National Institutes of Health
- Guidance on Page Limits for Specific Aims for Fundamental-Plus or Expanded applications for PAR-20-312, NIOSH State Occupational Safety and Health Surveillance Program (U60)
National Institute for Occupational Safety and Health
Notice of Changes to Funding Opportunities
- Notice of Extension of the Expiration Date for PAR-18-578 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)"
National Institute on Alcohol Abuse and Alcoholism
- Notice of Clarification of Award Budget Instructions for the Opportunity Pool within RFA-DK-20-014, Reconfiguration of GenitoUrinary Development Molecular Anatomy Project (GUDMAP) /(Re)Building A Kidney (RBK) Data Hub (U24 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- NEI Notice of Participation in PA-20-202, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)"
National Eye Institute
- NEI Notice of Participation in PA-20-206, "Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)"
National Eye Institute
- Notice of Early Expiration of PAR-20-039 "Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice of Addition of AIDS Application Due Dates to PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
National Institute of General Medical Sciences
- Notice of Change to the Number of Applications that Can Be Submitted by Institutions Applying to PAR-21-026 "Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice of Change to the Number of Applications that Can Be Submitted by Institutions Applying to PAR-21-025 "Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice of Early Expiration of PAR-20-040 "Support of Competitive Research (SCORE) Pilot Project Award (SC2 Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice of Early Expiration of PAR-20-041 "Support of Competitive Research (SCORE) Research Continuance Award (SC3 Clinical Trial Not Allowed)"
National Institute of General Medical Sciences
- Notice of Change in Scientific/Research Contact for PAR-20-304, "Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)".
National Library of Medicine
- Notice of Correction to the Expiration Date of RFA-MH-21-140 "BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)"
National Institute of Mental Health
- Notice of NINDS Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence (SuRE)
National Institute of General Medical Sciences
- Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Access to Research Careers (T34 Clinical Trial Not Allowed)
National Institute of General Medical Sciences
- Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence - First Independent Research Support & Transition (SuRE-First)
National Institute of General Medical Sciences
- Notice of Intent to Publish a Funding Opportunity Announcement for a National Resource Center for the Support for Research Excellence (SuRE) Program
National Institute of General Medical Sciences
- Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
National Institute on Minority Health and Health Disparities
- Notice of Intent to Publish the Reissuance of Building Interdisciplinary Research Careers in Women's Health Program (K12 Clinical Trial Optional)
Office of Research on Women's Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Tailoring Follow-up Care for Survivors Using Risk-Stratified Pathways
National Cancer Institute
- Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts
National Human Genome Research Institute
Funding Opportunities
- NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
National Institute on Deafness and Other Communication Disorders
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
National Institute on Deafness and Other Communication Disorders
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required)
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 No Independent Clinical Trials)
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
National Institute on Deafness and Other Communication Disorders
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
- Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed)
National Institute on Aging
- NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed)
National Cancer Institute
- Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R43 Clinical Trial Not Allowed)
- Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional
Food and Drug Administration
- Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01) Clinical Trials Optional
Food and Drug Administration
- Mood Disorders in People Living with HIV: Mechanisms and Pathways (R01 Clinical Trial Optional)
- Mood Disorders in People Living with HIV: Mechanisms and Pathways (R21 Clinical Trial Optional)
National Institute of Mental Health
- Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed)
National Center for Advancing Translational Sciences
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu